Inside the Rise of circRNA
July 9, 2026
Circio CEO Erik Wiklund reflects on the discovery of human circular RNA and its evolution into a fast-moving therapeutic modality
11 min read
False
Advertisement
Drug Discovery
Are Researchers Learning to Trust AI?
July 8, 2026
Elsevier’s Mirit Eldor explores the gap between AI adoption and AI confidence, drawing on findings from the Researcher of the Future report
7 min read
AI Framework Helps Identify New CAR T Target
July 6, 2026
A human-in-the-loop AI strategy helped narrow more than 10,000 candidates to a CAR T target now validated in mouse models
2 min read
CAR T Cells Target TNF in Mouse Model of Rheumatoid Arthritis
June 30, 2026
A single infusion of engineered T cells degraded soluble TNF and produced durable disease control in mice
2 min read
Reformulating the Future of Small Molecules
June 30, 2026
A special collection of recent stories exploring oral dose innovation, API stability, nitrosamine testing, and the evolving science of small molecule medicines
1 min read
Rewriting the Neuroscience Playbook
By James Strachan
June 23, 2026
Merz Therapeutics is exploring botulinum toxin in chronic pain – a test case for unconventional thinking in neuroscience drug development
4 min read
Earendil: A Blueprint for a Multipolar Life Sciences Era
By Joe Renny
June 5, 2026
The $787M financing points to a new global architecture in biotech
5 min read
HTC-19 Profile: What’s Cooking in the mRNA Lab?
June 3, 2026
Jonathan Maurer of the University of Geneva discusses his work with Sanofi and Waters – and why good analytical science has a lot in common with good cooking
3 min read
When Insight Meets Urgency in Cell and Gene Therapy
By Ruizhi Wang, Alan J. Dickson
May 27, 2026
Balancing deep biological insight with the realities of development is now central to progress in advanced medicine
6 min read
The Secrets of the Gut
April 20, 2026
Going beyond the gut: why microbiome testing is the next big thing in drug development
3 min read
